RxDoctor Payments Data

Dipti Anand, MD

Dermatopathology · Smyrna, GANPI 1811041049

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $9,300 of the $11,098 with a category attached, or 83.8%. Stemline Therapeutics Inc. accounts for 98.9% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $7,519 and has fallen 79.8% since, to $1,522 in 2023. Among dermatopathology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,098in general payments, 2019–2025

Across 15 payments — averaging $739.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stemline Therapeutics Inc.$11K
  • UCB, Inc.$122

What the payments were for

  • Speaking & faculty fees$9,30084%
  • Travel & lodging$1,34312%
  • Food & beverage$4384%
  • Education$170%

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stemline Therapeutics Inc.14$10,976
UCB, Inc.1$122

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,098 in reported general payments places this provider in the 90th percentile of 25 dermatopathology providers in Georgia.

See all dermatopathology providers in Georgia

Medicare billing

Part B allowed, 2024
$2,679,662
Medicare patients
15,998
Services billed
35,726

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatopathology in Smyrna

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →